Inventor · disambiguated record
Sultan Chowdhury
Also filed as: CHOWDHURY SULTAN
44 granted patents·18 pending applications·496 citations·filing 2004–2021
98Inventor score
Files withXENON PHARMACEUTICALS INC26GENENTECH INC24CHAFEEV MIKHAIL7CADIEUX JEAN-JACQUES3CHOWDHURY SULTAN1
Top patents by PatentIndex Score
62 records- 0197US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0296US10815229B1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Oct 27, 2020·4 cites·29 claims
- 0395US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0495US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0595US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0695US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0793US8101647B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 24, 2012·35 cites·37 claims
- 0892US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 0992US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 1092US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 1192US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 1292US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 1391US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 1491US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 1591US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 1691US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 1790US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 1889US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 1988US7777036B2Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·13 cites·9 claims
- 2087US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 2187US9493429B2Substituted benzoxazoles and methods of use thereofGENENTECH INC·Filed 2014·Granted Nov 15, 2016·10 cites·24 claims
- 2287US8742109B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2012·Granted Jun 3, 2014·12 cites·6 claims
- 2385US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 2485US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 2584US8445696B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2010·Granted May 21, 2013·9 cites·8 claims
- 2683US9550775B2Substituted triazolopyridines and methods of use thereofGENENTECH INC·Filed 2014·Granted Jan 24, 2017·7 cites·26 claims
- 2782US10766858B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2017·Granted Sep 8, 2020·1 cites·19 claims
- 2882US9695185B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·3 cites·1 claims
- 2982US9487535B2Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Nov 8, 2016·5 cites·26 claims
- 3082US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 3181US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 3279US9260446B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·4 cites·5 claims
- 3376US10787446B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 29, 2020·1 cites·26 claims
- 3476US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 3575US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 3673US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 3771US7829712B2Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted Nov 9, 2010·1 cites·16 claims
- 3870US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 3970US10071957B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Sep 11, 2018·1 cites·2 claims
- 4069US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4167US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4264US2015224071A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 4360US11203572B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2020·Granted Dec 21, 2021·0 cites·20 claims
- 4460US2021171516A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 4558US2021253548A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 4656US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4756US2017002017A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 4853US2011269788A1Spiro-oxindole-derivatives as sodium channel blockersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4953US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 5051US2018346416A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →